Cargando…
Inhibition of Phosphoglycerate Dehydrogenase Radiosensitizes Human Colorectal Cancer Cells under Hypoxic Conditions
SIMPLE SUMMARY: Colorectal cancer is the third most prevalent cancer worldwide. Treatment options for these patients consist of surgery combined with chemotherapy and/or radiotherapy. However, a subset of tumors will not respond to therapy or acquire resistance during the course of the treatment, le...
Autores principales: | Van de Gucht, Melissa, Dufait, Inès, Kerkhove, Lisa, Corbet, Cyril, de Mey, Sven, Jiang, Heng, Law, Ka Lun, Gevaert, Thierry, Feron, Olivier, De Ridder, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599856/ https://www.ncbi.nlm.nih.gov/pubmed/36291844 http://dx.doi.org/10.3390/cancers14205060 |
Ejemplares similares
-
Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells
por: de Mey, Sven, et al.
Publicado: (2020) -
Repurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer
por: Kerkhove, Lisa, et al.
Publicado: (2023) -
Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption
por: de Mey, Sven, et al.
Publicado: (2018) -
Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species
por: Wang, Hui, et al.
Publicado: (2017) -
Structure–Activity Relationships (SARs) of α-Ketothioamides as Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)
por: Spillier, Quentin, et al.
Publicado: (2020)